CLINICAL_TRIALS
trial_result
· 2017-12-02
Clinical Trial Update: Treating H. Pylori in Parkinson's Patients With Motor Fluctuations [Phase 3]
Summary
A Phase 3 trial evaluating Helicobacter pylori eradication in Parkinson's disease patients with motor fluctuations was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of California, Los Angeles | Conditions: Parkinson's Disease, Helicobacter Infections | Phase 3 | Status: TERMINATED | Results posted: 2017-12-02